FOXM1 evokes 5-fluorouracil resistance in colorectal cancer depending on ABCC10

5-Fluorouracil (5-FU) is the most commonly used chemotherapeutic agent for colorectal cancer (CRC). However, frequently occurred 5-FU resistance poses a great challenge in the clinic. Elucidating the underlying mechanisms and developing effective strategies against 5-FU resistance are highly desired...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Xie, Tao, Geng, Jian, Wang, Ye, Wang, Liya, Huang, Mengxi, Chen, Jing, Zhang, Kai, Xue, Lijun, Liu, Xiaobei, Mao, Xiaobei, Chen, Yanan, Wang, Qian, Dai, Tingting, Ren, Lili, Yu, Hongju, Wang, Rui, Chen, Longbang, Chen, Cheng, Chu, Xiaoyuan
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2016
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5352423/
https://ncbi.nlm.nih.gov/pubmed/28051999
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.14351
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados